Kargoszyn, Poland

Mateusz Jaskolowski

This inventor holds 1 USPTO granted patent. Top assignees: The University of Chicago, University of Virginia Patent Foundation. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mateusz Jaskolowski. Retrieved from https://idiyas.com/inventor/mateusz-jaskolowski

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Mateusz Jaskolowski

Introduction

Mateusz Jaskolowski is a notable inventor based in Kargoszyn, Poland. He has made significant contributions to the field of biotechnology, particularly in the development of recombinant antibodies. His work focuses on addressing critical health challenges, such as those posed by the Ebola virus.

Latest Patents

Jaskolowski holds a patent for "Recombinant antibodies that recognize the C-terminal domains of Ebola virus nucleoprotein." This patent is directed towards compositions and methods that utilize the boundaries of the C-terminal domains of Nucleoprotein from the Zaire Ebola virus. These highly stable recombinant protein antigens are designed to generate antibodies for the diagnosis and treatment of Ebola virus infection. He has 1 patent to his name.

Career Highlights

Throughout his career, Jaskolowski has worked with prestigious institutions, including the University of Virginia Patent Foundation and the University of Chicago. His experience in these organizations has allowed him to advance his research and contribute to significant scientific advancements.

Collaborations

Jaskolowski has collaborated with esteemed colleagues such as Zygmunt S Derewenda and Daniel A Engel. These partnerships have further enriched his research and innovation efforts.

Conclusion

Mateusz Jaskolowski's work in developing recombinant antibodies represents a vital step in combating viral infections like Ebola. His contributions to biotechnology and his collaborations with leading researchers highlight his commitment to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…